Articles

Desmopressin in moderate hemophilia A patients: a treatment worth considering

Department of Pediatric Hematology, Immunology and Infectious diseases, Emma Children’s Hospital, Amsterdam, the Netherlands
Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands
Division of Haematology/Oncology, Department of Paediatrics and Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada
Division of Hematology, Department of Medicine, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
Department of Pediatric Hematology, Immunology and Infectious diseases, Emma Children’s Hospital, Amsterdam, the Netherlands
Department of Pediatric Hematology, Immunology and Infectious diseases, Emma Children’s Hospital, Amsterdam, the Netherlands
A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ca’ Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy
Aghia Sofia Children’s Hospital, Athens, Greece
Maastricht University Medical Centre, the Netherlands
Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands
Leiden University Hospital, the Netherlands;Sanquin Research, Leiden, the Netherlands
Department of Pediatric Hematology, Immunology and Infectious diseases, Emma Children’s Hospital, Amsterdam, the Netherlands;Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands
Vol. 103 No. 3 (2018): March, 2018 https://doi.org/10.3324/haematol.2017.180059